FDA In Brief: FDA seeks input on development and evaluation of abuse-deterrent formulations of central nervous system stimulants

Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/14/2025
Short Title (70 char) Pine Pharmaceuticals LLC. Tonawanda, NY. 483 issued 11/14/2025
FEI Number 3010943533
Firm Name Pine Pharmaceuticals LLC
Record Type 483
State NY
Establishment Type

Juniper Granola, LLC. of Rochester, NY is recalling CHOCOLATE CHERRY and PEANUT BUTTER CHOCOLATE CHIP Junebars with printed batch label L1300 or L1301 because it may contain undeclared milk and soy. People who have an allergy or severe sensitivity to milk or soy run the risk of serious or life-threa

On September 30, 2022, the President signed into law the FDA User Fee Reauthorization Act of 2022.

Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs).

CGMP/OTC/Unapproved New Drugs/Misbranded

Wholesale Produce Supply of Minneapolis, Minnesota is Recalling Fresh Cut/Processed Cantaloupe, Because it has the Potential to be Contaminated With Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with